<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR75">
 <label>75</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brisson</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Laprise</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Drolet</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Van de Velde</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Franco</surname>
    <given-names>EL</given-names>
   </name>
   <name>
    <surname>Kliewer</surname>
    <given-names>EV</given-names>
   </name>
   <name>
    <surname>Ogilvie</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Deeks</surname>
    <given-names>SL</given-names>
   </name>
   <name>
    <surname>Boily</surname>
    <given-names>MC</given-names>
   </name>
  </person-group>
  <article-title>Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study</article-title>
  <source>Vaccine</source>
  <year>2013</year>
  <volume>31</volume>
  <issue>37</issue>
  <fpage>3863</fpage>
  <lpage>871</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.06.064</pub-id>
  <?supplied-pmid 23830974?>
  <pub-id pub-id-type="pmid">23830974</pub-id>
 </element-citation>
</ref>
